Dear SPS Member:
As part of the SPS strategic plan, the Society is working closely with other scientific organization to provide edcuational opportunities. SPS is a sponsor for the upcoming 1.5-day workshop entitled Stem cell-derived Cardiomyocytes as Models of Cardiac Pathobiology and Toxicity that will take place October 30-31, 2012 at the Amgen, Inc. facility in Cambridge, Massachusetts. The overall meeting is being organized by the ILSI Health and Environmental Sciences Institute’s (HESI) Technical Committee on Cardiac Safety Stem Cell Workshop Planning Committee.
This is one and a half-day workshop will be dedicated to scientific presentations, roundtable discussions and a poster session to discuss the state of the science as well as challenges and future opportunities in the field. The workshop objective is to bring together an international and multi-disciplinary group of scientists to evaluate the use of stem cell platforms and associated technologies in the nonclinical cardiovascular risk assessment of pharmaceuticals and environmental chemicals.
Who should attend? Interdisciplinary scientists from academia, government, clinical medicine, and industry interested in stem cell-derived cardiomyocyte assay platforms in pharmaceutical and environmental chemical hazard identification.
Workshop details and a draft agenda linked here with more information. Register online at: http://www.hesiglobal.org/files/public/Committees/Cardiac%20Safety/StemCellWorkshopFlyerV3.pdfe. The registration deadline is Monday, October 22, 2012! Please email me at firstname.lastname@example.org for more information.